# Biwen Mo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/biwen-mo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 995 |
| Field | Asthma and respiratory diseases |
| h-index | 15 |
| i10-index | 18 |
| Last Known Institution | Guangxi Medical University |
| OpenAlex ID | https://openalex.org/A5101507880 |
| ORCID iD | 0000-0003-3667-0076 |
| Works | 64 |

## Researcher papers

- [MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program](https://scholariq.org/papers/mbd2-serves-as-a-viable-target-against-pulmonary-fibrosis-by-inhibiting/)
- [IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages](https://scholariq.org/papers/il-24-deficiency-protects-mice-against-bleomycin-induced-pulmonary-fibrosis-by/)
- [Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation](https://scholariq.org/papers/blockade-of-jak2-protects-mice-against-hypoxia-induced-pulmonary-arterial/)
- [LPS enhances TLR4 expression and IFN-γ production via the TLR4/IRAK/NF-κB signaling pathway in rat pulmonary arterial smooth muscle cells](https://scholariq.org/papers/lps-enhances-tlr4-expression-and-ifn-production-via-the-tlr4-irak-nf-b-signaling/)
- [Artesunate ameliorates lung fibrosis via inhibiting the Notch signaling pathway](https://scholariq.org/papers/artesunate-ameliorates-lung-fibrosis-via-inhibiting-the-notch-signaling-pathway/)
- [Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer](https://scholariq.org/papers/musashi1-as-a-potential-therapeutic-target-and-diagnostic-marker-for-lung-cancer/)
- [Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts](https://scholariq.org/papers/elongation-factor-2-kinase-acts-downstream-of-p38-mapk-to-regulate-proliferation/)
- [Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial](https://scholariq.org/papers/safety-and-efficacy-of-oral-nemonoxacin-versus-levofloxacin-in-treatment-of/)
- [Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis](https://scholariq.org/papers/targeted-resequencing-reveals-genetic-risks-in-patients-with-sporadic-idiopathic/)
- [Expression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopy](https://scholariq.org/papers/expression-of-seven-stem-cell-associated-markers-in-human-airway-biopsy/)
- [Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats](https://scholariq.org/papers/artesunate-modulates-expression-of-matrix-metalloproteinases-and-their/)

## Researcher topics

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Pediatric health and respiratory diseases](https://scholariq.org/topics/pediatric-health-and-respiratory-diseases/)

## Researcher university

- [Guangxi Medical University](https://scholariq.org/institutions/guangxi-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.